rs2633851

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182760.4(SUMF1):​c.*11A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.58 in 1,611,076 control chromosomes in the GnomAD database, including 276,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.64 ( 31464 hom., cov: 33)
Exomes 𝑓: 0.57 ( 245449 hom. )

Consequence

SUMF1
NM_182760.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.812

Publications

16 publications found
Variant links:
Genes affected
SUMF1 (HGNC:20376): (sulfatase modifying factor 1) This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
SUMF1 Gene-Disease associations (from GenCC):
  • mucosulfatidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 3-4362133-T-A is Benign according to our data. Variant chr3-4362133-T-A is described in ClinVar as Benign. ClinVar VariationId is 96558.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.751 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SUMF1NM_182760.4 linkc.*11A>T 3_prime_UTR_variant Exon 9 of 9 ENST00000272902.10 NP_877437.2 Q8NBK3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SUMF1ENST00000272902.10 linkc.*11A>T 3_prime_UTR_variant Exon 9 of 9 1 NM_182760.4 ENSP00000272902.5 Q8NBK3-1

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96440
AN:
151888
Hom.:
31421
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.758
Gnomad AMI
AF:
0.603
Gnomad AMR
AF:
0.678
Gnomad ASJ
AF:
0.619
Gnomad EAS
AF:
0.757
Gnomad SAS
AF:
0.751
Gnomad FIN
AF:
0.582
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.542
Gnomad OTH
AF:
0.641
GnomAD2 exomes
AF:
0.634
AC:
158118
AN:
249370
AF XY:
0.631
show subpopulations
Gnomad AFR exome
AF:
0.770
Gnomad AMR exome
AF:
0.738
Gnomad ASJ exome
AF:
0.600
Gnomad EAS exome
AF:
0.764
Gnomad FIN exome
AF:
0.576
Gnomad NFE exome
AF:
0.550
Gnomad OTH exome
AF:
0.605
GnomAD4 exome
AF:
0.575
AC:
838431
AN:
1459070
Hom.:
245449
Cov.:
34
AF XY:
0.578
AC XY:
419951
AN XY:
725950
show subpopulations
African (AFR)
AF:
0.769
AC:
25723
AN:
33444
American (AMR)
AF:
0.725
AC:
32399
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.595
AC:
15547
AN:
26110
East Asian (EAS)
AF:
0.773
AC:
30663
AN:
39666
South Asian (SAS)
AF:
0.735
AC:
63360
AN:
86192
European-Finnish (FIN)
AF:
0.574
AC:
30622
AN:
53350
Middle Eastern (MID)
AF:
0.628
AC:
3517
AN:
5604
European-Non Finnish (NFE)
AF:
0.541
AC:
600693
AN:
1109732
Other (OTH)
AF:
0.596
AC:
35907
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
16815
33629
50444
67258
84073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17252
34504
51756
69008
86260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.635
AC:
96534
AN:
152006
Hom.:
31464
Cov.:
33
AF XY:
0.641
AC XY:
47628
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.758
AC:
31461
AN:
41516
American (AMR)
AF:
0.678
AC:
10356
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.619
AC:
2144
AN:
3466
East Asian (EAS)
AF:
0.758
AC:
3905
AN:
5154
South Asian (SAS)
AF:
0.751
AC:
3623
AN:
4824
European-Finnish (FIN)
AF:
0.582
AC:
6137
AN:
10550
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.542
AC:
36819
AN:
67908
Other (OTH)
AF:
0.645
AC:
1362
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1781
3562
5343
7124
8905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.497
Hom.:
2497
Bravo
AF:
0.649
Asia WGS
AF:
0.770
AC:
2679
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 26, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Multiple sulfatase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.4
DANN
Benign
0.58
PhyloP100
0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2633851; hg19: chr3-4403817; COSMIC: COSV55991857; API